Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EPS (Weighted Average and Diluted) (2016 - 2025)

INVO Fertility (IVF) has disclosed EPS (Weighted Average and Diluted) for 15 consecutive years, with -$0.77 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 98.66% to -$0.77 in Q3 2025 year-over-year; TTM through Sep 2025 was $12.2, a 108.18% increase, with the full-year FY2024 number at -$30.19, up 55.19% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.77 for Q3 2025 at INVO Fertility, up from -$3.19 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $28.69 in Q4 2024 to a low of -$61.61 in Q4 2023.
  • A 5-year average of -$8.16 and a median of -$3.06 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 15266.67% in 2022, then soared 146.57% in 2024.
  • INVO Fertility's EPS (Weighted Average and Diluted) stood at $0.03 in 2021, then plummeted by 15266.67% to -$4.55 in 2022, then tumbled by 1254.07% to -$61.61 in 2023, then soared by 146.57% to $28.69 in 2024, then crashed by 102.68% to -$0.77 in 2025.
  • Per Business Quant, the three most recent readings for IVF's EPS (Weighted Average and Diluted) are -$0.77 (Q3 2025), -$3.19 (Q2 2025), and -$12.53 (Q1 2025).